Cannabinoid1 (CB‐1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose
Published in 2020 by the Journal of Neural Transmission.
Published in April 2019 by ASPET Journals.
Published in March 2019 by American College of Neuropsychopharmacology.
Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose
Published in 2019 by the Journal of Clinical Pharmacology.
Published in 2018 by the European Journal of Pharmacology.
Published in 2018 by the Science Translational Medicine.
Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625
Published in 2010 by the Journal of Psychopharmacology.
A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse
Published in 2017 in the Journal of Medicinal Chemistry.
Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose
Published in 2016 by the American College of Clinical Pharmacology.